Jennifer Ruff
Investor Relations Contact at DIANTHUS THERAPEUTICS, INC.
Profile
Jennifer Davis Ruff is currently the VP, Head-Investor Relations & Corporate Affairs at Dianthus Therapeutics, Inc. She previously worked as the Director-Investor Relations at Pfizer Inc. from 2007 to 2013, as the VP-Corporate Communications & Investor Relations at Tesaro, Inc. from 2013 to 2018, and as Investor Relations & Corporate Communications at MGI PHARMA Biologics, Inc. from 2003 to 2007.
Jennifer also briefly served as the Vice President-Investor Relations at Pyxis Oncology, Inc. in 2023.
She holds a graduate degree from Northwestern University and an undergraduate degree from the University of Iowa.
Jennifer Ruff active positions
| Companies | Position | Start |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Investor Relations Contact | 28/11/2023 |
Former positions of Jennifer Ruff
| Companies | Position | End |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Investor Relations Contact | 31/10/2023 |
| TESARO INC | Investor Relations Contact | 30/09/2018 |
| PFIZER, INC. | Investor Relations Contact | 28/02/2013 |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Public Communications Contact | 30/04/2007 |
Training of Jennifer Ruff
| Northwestern University | Graduate Degree |
| University of Iowa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
MGI PHARMA Biologics, Inc.
MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Ruff
